ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Medically Supervised Online Weight Loss Program With GLP-1 Medications Announced

OrderlyMeds has announced new openings for its online weight loss program, which includes tailored GLP-1 medications and lifestyle guidance.

-- Individuals aged 18 and older with a BMI of over 25 can now enroll in OrderlyMeds' program for medically supervised GLP-1 or GIP therapy, as well as coaching for nutrition and physical activity for long-term weight management. As it is a fully online program, patients will receive customized medications by mail, and appointments will be carried out over telehealth.

For more information, please visit https://orderlymeds.com/how-it-works/

OrderlyMeds’ weight loss programs begin with a virtual consultation during which the patient’s eligibility will be evaluated through a short questionnaire, and they will be provided with recommendations for GLP-1 therapy. Licensed medical providers will then schedule a text-based telehealth visit with the individual to ensure they are prescribed the appropriate medication at the correct dose. Once this prescription is approved by the platform’s medical team, partnered pharmacies will fill and ship the medication via tracked postage, which will arrive at the client’s address within five to six days.

GLP-1 and GLP-1/GIP medications offered through OrderlyMeds’ programs include Zepbound (tirzepatide) and Wegovy (semaglutide), but compounded injections are also offered when deemed medically appropriate. As all individuals respond differently to GLP-1 therapy, OrderlyMeds’ licensed physicians will monitor each patient closely to determine whether they require dosage changes at any point during their treatment.

In addition to medications, the platform provides ongoing support for lifestyle modifications that can aid with long-term weight management. Customers will be provided with specialized meal plans designed for GLP-1 patients to complement treatment; they will also have access to a workout app and exercise regimens that will help them attain their health goals. Mental health support is also available through BetterHelp and will be provided for free for the first month.

About OrderlyMeds

OrderlyMeds is a telehealth weight loss provider that is committed to making medically supervised weight loss accessible to all patients. To date, the platform has helped over 57,000 customers achieve weight loss through its online programs.

A satisfied patient said, “I was skeptical about purchasing from any online vendor, but after I did some research, I put my trust in OrderlyMeds. And I’m so glad that I did! The process was smooth, and I got my meds very quickly. But the customer service is the reason I will continue using them. It’s absolutely top-tier!”

More information is available at https://orderlymeds.com/

Contact Info:
Name: Annie Dawson
Email: Send Email
Organization: OrderlyMeds
Address: 235 Ponce De Leon Pl Suite M347, Decatur, Georgia 30030, United States
Website: https://orderlymeds.com/

Source: PressCable

Release ID: 89186280

In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.14
+4.77 (2.32%)
AAPL  251.49
+3.50 (1.41%)
AMD  202.68
+1.35 (0.67%)
BAC  47.52
+0.36 (0.76%)
GOOG  299.02
+0.23 (0.08%)
META  604.06
+10.40 (1.75%)
MSFT  383.00
+1.13 (0.30%)
NVDA  175.64
+2.94 (1.70%)
ORCL  154.34
+4.66 (3.11%)
TSLA  380.85
+12.89 (3.50%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.